Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This piece explains what sequence of returns risk is in retirement, why it matters for retirement income, and how to interpret its effects on portfolios.
26,990 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
In June, Lemonade stock surged about 12% as investors weighed progress on its reinsurance strategy and AI-driven grow...
Could Bloom Energy ride AI demand like Nvidia did? This comprehensive guide weighs the parallels, the risks, and prac...
A booming demand backdrop for chips collides with sky-high spending. This piece breaks down what Taiwan Semiconductor...
A New York-based issuer sells rated notes backed by a pool of bitcoin-backed consumer loans, signaling a milestone fo...
New federal data outline where gun thefts concentrate, revealing which states bear the heaviest burden and why safety...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
A once-observed signal is flashing green again: the metric that preceded every BTC rally has appeared, as negative fu...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
A leading AI company hints at a monumental goal: $9 trillion in market value. We explore what that could mean for inv...
As the Senate Banking Committee prepares a pivotal vote, crypto stakeholders weigh the potential for regulatory clari...